Concepedia

Publication | Open Access

Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis

DOIFull Paper Access

26

Citations

32

References

2018

Year

Han Joo Baek, Mie Jin Lim, Won Park, Sung Hwan Park, Seung Cheol Shim, Dae‐Hyun Yoo, Hyun Ah Kim, Soo Kon Lee, Yun Jong Lee, Young Eun Park,
The Korean Journal of Internal Medicine

Abstract

TCZ infusion add-on is highly efficacious and well-tolerated in Korean patients with active RA refractory to conventional DMARDs including MTX. EULAR good response at week 12 could predict DAS28 remission at week 72.

References

YearCitations

Page 1